학술논문
A phase 1 study to evaluate the safety and pharmacokinetics of MEDI8852, an anti-influenza A monoclonal antibody, in healthy adult volunteers
Document Type
Article
Source
In Biologicals November 2017 50:81-86
Subject
Language
ISSN
1045-1056